Category: Cosmetic/AestheticSyndicate content

Medical device manufacturers making cosmetic / aesthetic products.

Breast implant maker Sientra registers an $86M IPO

September 23, 2014 by Arezu Sarvestani

Medical aesthetics company Sientra files registration documents for an initial public offering proposed to raise as much as $86.3 million.

Breast implants: Sientra registers an $86M IPO

California medical device maker Sientra Inc. is looking to hit the public markets with an initial public offering that could raise as much as $86.3 million, according to an SEC filing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan cuts 129 workers amid hostile takeover battle

September 12, 2014 by Arezu Sarvestani

California-based Allergan informs state regulators that it plans to permanently lay off 129 employees.

Allergan cuts 129 workers amid hostile takover battle

Embattled aesthetic devices maker Allergan (NYSE:AGN) informed California state authorities that it plans to cut 129 workers over the next few weeks.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cynosure drops $13.2M on Ellman's RF devices

September 8, 2014 by Arezu Sarvestani

Cynosure rounds out its minimally and non-invasive aesthetics portfolio with the $13.2 million acquisition of Ellman Intl. and its radiofrequency devices.

Cynosure drops $13.2M on Ellman's RF devices

Massachusetts-based Cynosure (NSDQ:CYNO) is looking to expand its market with new radiofrequency-based devices picked up in its $13.2 million acquisition of Ellman Intl.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Allergan accedes to special meeting, asks court to block Valeant's vote

August 27, 2014 by Arezu Sarvestani

Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares.

Allergan accedes to special meeting, asks court to block Valeant's vote

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Feds take a closer look at Valeant's hostile bid for Allergan

August 11, 2014 by Arezu Sarvestani

The FTC issued a "Second Request" for more information about Valeant Pharmaceuticals' ongoing attempts to take over Allergan.

Feds take a closer look at Valeant's hostile bid for Allergan

Federal authorities are taking a closer look at Allergan's (NYSE:AGN) ongoing battle to keep unrequited acquirer Valeant Pharmaceuticals at bay.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Valeant's hostile takeover hopes fade as Allergan war continues

August 6, 2014 by Arezu Sarvestani

Allergan uses the occasion of unrequited buyer Valeant Pharmaceuticals' latest financial report to drive home allegations that Valeant isn't being upfront about its business and accounting practices.

Allergan attacks activist investor's latest earnings report

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ulthera pulls $86M IPO in favor of $600M merger

July 23, 2014 by Arezu Sarvestani

Aesthetics devices maker Ulthera withdraws its $86 million initial public offering after agreeing to an acquisition by Merz that's valued at up to $600 million.

Ulthera pulls IPO in favor of merger

Arizona device maker Ulthera is ditching its planned initial public offering in favor of a $600 million merger with larger aesthetics company Merz Inc., according to an SEC filing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp